Logo image of ACVA

ACV AUCTIONS INC-A (ACVA) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:ACVA - US00091G1040 - Common Stock

7.81 USD
-0.18 (-2.25%)
Last: 12/15/2025, 8:04:00 PM
7.81 USD
0 (0%)
After Hours: 12/15/2025, 8:04:00 PM
Fundamental Rating

3

Overall ACVA gets a fundamental rating of 3 out of 10. We evaluated ACVA against 82 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of ACVA have multiple concerns. While showing a medium growth rate, ACVA is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

ACVA had negative earnings in the past year.
ACVA had a positive operating cash flow in the past year.
ACVA had negative earnings in each of the past 5 years.
In multiple years ACVA reported negative operating cash flow during the last 5 years.
ACVA Yearly Net Income VS EBIT VS OCF VS FCFACVA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M -100M

1.2 Ratios

With a Return On Assets value of -6.23%, ACVA is not doing good in the industry: 67.07% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -16.74%, ACVA is doing worse than 64.63% of the companies in the same industry.
Industry RankSector Rank
ROA -6.23%
ROE -16.74%
ROIC N/A
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ACVA Yearly ROA, ROE, ROICACVA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -10 -20 -30

1.3 Margins

ACVA has a Gross Margin of 53.30%. This is amongst the best in the industry. ACVA outperforms 93.90% of its industry peers.
In the last couple of years the Gross Margin of ACVA has grown nicely.
ACVA does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 53.3%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
ACVA Yearly Profit, Operating, Gross MarginsACVA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

ACVA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ACVA has been increased compared to 1 year ago.
ACVA has more shares outstanding than it did 5 years ago.
ACVA has a worse debt/assets ratio than last year.
ACVA Yearly Shares OutstandingACVA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M
ACVA Yearly Total Debt VS Total AssetsACVA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

ACVA has an Altman-Z score of 1.26. This is a bad value and indicates that ACVA is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ACVA (1.26) is worse than 70.73% of its industry peers.
The Debt to FCF ratio of ACVA is 4.81, which is a neutral value as it means it would take ACVA, 4.81 years of fcf income to pay off all of its debts.
ACVA has a better Debt to FCF ratio (4.81) than 70.73% of its industry peers.
A Debt/Equity ratio of 0.51 indicates that ACVA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.51, ACVA is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 4.81
Altman-Z 1.26
ROIC/WACCN/A
WACC8.28%
ACVA Yearly LT Debt VS Equity VS FCFACVA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

ACVA has a Current Ratio of 1.62. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of ACVA (1.62) is comparable to the rest of the industry.
ACVA has a Quick Ratio of 1.62. This is a normal value and indicates that ACVA is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.62, ACVA is in the better half of the industry, outperforming 62.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.62
Quick Ratio 1.62
ACVA Yearly Current Assets VS Current LiabilitesACVA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

6

3. Growth

3.1 Past

ACVA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.43%, which is quite impressive.
ACVA shows a strong growth in Revenue. In the last year, the Revenue has grown by 23.40%.
Measured over the past years, ACVA shows a very strong growth in Revenue. The Revenue has been growing by 42.93% on average per year.
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
Revenue 1Y (TTM)23.4%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%16.48%

3.2 Future

The Earnings Per Share is expected to grow by 37.83% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 15.14% on average over the next years. This is quite good.
EPS Next Y13.94%
EPS Next 2Y22.69%
EPS Next 3Y23.07%
EPS Next 5Y37.83%
Revenue Next Year19.38%
Revenue Next 2Y15.46%
Revenue Next 3Y15.09%
Revenue Next 5Y15.14%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ACVA Yearly Revenue VS EstimatesACVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B
ACVA Yearly EPS VS EstimatesACVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 1 2

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACVA. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACVA. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACVA Price Earnings VS Forward Price EarningsACVA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACVA indicates a somewhat cheap valuation: ACVA is cheaper than 60.98% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 29.38
EV/EBITDA N/A
ACVA Per share dataACVA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

ACVA's earnings are expected to grow with 23.07% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y22.69%
EPS Next 3Y23.07%

0

5. Dividend

5.1 Amount

ACVA does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ACV AUCTIONS INC-A

NYSE:ACVA (12/15/2025, 8:04:00 PM)

After market: 7.81 0 (0%)

7.81

-0.18 (-2.25%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)02-17 2026-02-17/amc
Inst Owners101.59%
Inst Owner Change-3.81%
Ins Owners2.45%
Ins Owner Change-2.51%
Market Cap1.34B
Revenue(TTM)735.48M
Net Income(TTM)-72.72M
Analysts78.1
Price Target10.67 (36.62%)
Short Float %6.11%
Short Ratio2.43
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)46.46%
Min EPS beat(2)35.62%
Max EPS beat(2)57.31%
EPS beat(4)3
Avg EPS beat(4)26.91%
Min EPS beat(4)-9.21%
Max EPS beat(4)57.31%
EPS beat(8)6
Avg EPS beat(8)13.39%
EPS beat(12)10
Avg EPS beat(12)22.36%
EPS beat(16)13
Avg EPS beat(16)18.63%
Revenue beat(2)0
Avg Revenue beat(2)-2.65%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-2.13%
Revenue beat(4)0
Avg Revenue beat(4)-1.79%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)-0.24%
Revenue beat(8)2
Avg Revenue beat(8)-0.54%
Revenue beat(12)4
Avg Revenue beat(12)0.02%
Revenue beat(16)6
Avg Revenue beat(16)0.83%
PT rev (1m)-44.08%
PT rev (3m)-47.36%
EPS NQ rev (1m)5.21%
EPS NQ rev (3m)-33.04%
EPS NY rev (1m)-45.22%
EPS NY rev (3m)-50%
Revenue NQ rev (1m)-2.04%
Revenue NQ rev (3m)-5.51%
Revenue NY rev (1m)-1.37%
Revenue NY rev (3m)-1.52%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.83
P/FCF 29.38
P/OCF 15.39
P/B 3.1
P/tB 15.3
EV/EBITDA N/A
EPS(TTM)-0.32
EYN/A
EPS(NY)-0.24
Fwd EYN/A
FCF(TTM)0.27
FCFY3.4%
OCF(TTM)0.51
OCFY6.5%
SpS4.27
BVpS2.52
TBVpS0.51
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -6.23%
ROE -16.74%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 53.3%
FCFM 6.22%
ROA(3y)-9.14%
ROA(5y)-9.1%
ROE(3y)-18.55%
ROE(5y)-17.56%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y6.78%
GM growth 5Y18.27%
F-Score6
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 4.81
Debt/EBITDA N/A
Cap/Depr 97.26%
Cap/Sales 5.66%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.62
Quick Ratio 1.62
Altman-Z 1.26
F-Score6
WACC8.28%
ROIC/WACCN/A
Cap/Depr(3y)148.24%
Cap/Depr(5y)145.57%
Cap/Sales(3y)5.59%
Cap/Sales(5y)4.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%70%
EPS Next Y13.94%
EPS Next 2Y22.69%
EPS Next 3Y23.07%
EPS Next 5Y37.83%
Revenue 1Y (TTM)23.4%
Revenue growth 3Y21.14%
Revenue growth 5Y42.93%
Sales Q2Q%16.48%
Revenue Next Year19.38%
Revenue Next 2Y15.46%
Revenue Next 3Y15.09%
Revenue Next 5Y15.14%
EBIT growth 1Y36.9%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year167.91%
EBIT Next 3Y50.76%
EBIT Next 5Y36.81%
FCF growth 1Y344.71%
FCF growth 3Y-24.1%
FCF growth 5YN/A
OCF growth 1Y899.69%
OCF growth 3Y-8.47%
OCF growth 5YN/A

ACV AUCTIONS INC-A / ACVA FAQ

What is the ChartMill fundamental rating of ACV AUCTIONS INC-A (ACVA) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACVA.


What is the valuation status of ACV AUCTIONS INC-A (ACVA) stock?

ChartMill assigns a valuation rating of 2 / 10 to ACV AUCTIONS INC-A (ACVA). This can be considered as Overvalued.


What is the profitability of ACVA stock?

ACV AUCTIONS INC-A (ACVA) has a profitability rating of 2 / 10.


How financially healthy is ACV AUCTIONS INC-A?

The financial health rating of ACV AUCTIONS INC-A (ACVA) is 3 / 10.


Can you provide the expected EPS growth for ACVA stock?

The Earnings per Share (EPS) of ACV AUCTIONS INC-A (ACVA) is expected to grow by 13.94% in the next year.